BIOGEN INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Biogen Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Biogen Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $24.8M, a 41.9% decline year-over-year.
- Biogen Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $274M, a 102% increase year-over-year.
- Biogen Inc. annual Income Tax Expense (Benefit) for 2024 was $274M, a 102% increase from 2023.
- Biogen Inc. annual Income Tax Expense (Benefit) for 2023 was $135M, a 78.6% decline from 2022.
- Biogen Inc. annual Income Tax Expense (Benefit) for 2022 was $633M, a 1105% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)